Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA

TORRANCE, Calif., May 31, 2023 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, announced today that it has received a Medicine Registration Certificate (DRN-10164/23) from the Bahrain National Health Regulatory Authority (NHRA) granting…